Blue Chip Partners’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-1,779
Closed -$122K 159
2020
Q4
$122K Sell
1,779
-734
-29% -$47.7K 0.02% 136
2020
Q3
$147K Sell
2,513
-3,747
-60% -$233K 0.03% 117
2020
Q2
$407K Sell
6,260
-157
-2% -$9.89K 0.08% 75
2020
Q1
$381K Buy
6,417
+45
+0.7% +$3K 0.09% 75
2019
Q4
$473K Buy
6,372
+361
+6% +$25.3K 0.09% 91
2019
Q3
$379K Buy
6,011
+344
+6% +$20.4K 0.08% 95
2019
Q2
$309K Sell
5,667
-1,568
-22% -$84.4K 0.07% 99
2019
Q1
$390K Sell
7,235
-622
-8% -$38.4K 0.09% 94
2018
Q4
$515K Buy
7,857
+477
+6% +$35.6K 0.13% 88
2018
Q3
$581K Buy
7,380
+515
+8% +$36.8K 0.14% 81
2018
Q2
$442K Buy
6,865
+785
+13% +$51.7K 0.12% 91
2018
Q1
$378K Buy
6,080
+1,631
+37% +$117K 0.1% 100
2017
Q4
$323K Buy
4,449
+28
+0.6% +$2.04K 0.1% 99
2017
Q3
$360K Buy
4,421
+621
+16% +$49.1K 0.12% 99
2017
Q2
$306K Buy
3,800
+799
+27% +$63.1K 0.11% 99
2017
Q1
$236K Buy
+3,001
New +$240K 0.09% 106

Other funds holding CVS

Blue Chip Partners's CVS Position: Q1 2021 in Review

Blue Chip Partners sold out of CVS Health (CVS) in Q1 2021, closing a stake of 1,779 shares — an estimated $122K sold.

Blue Chip Partners first reported a position in CVS in Q1 2017 and held it in 16 quarters. The position peaked at $581K in Q3 2018. 2,032 funds tracked by Wall St. Rank hold CVS as of Q1 2021.

  • Blue Chip Partners reported no remaining CVS Health position as of Q1 2021 after selling out during the quarter.
  • Blue Chip Partners sold 1,779 CVS Health shares in Q1 2021, an estimated $122K.
  • Blue Chip Partners first reported a position in CVS Health in Q1 2017 and held it in 16 quarters.
  • Blue Chip Partners's CVS Health position peaked at $581K in Q3 2018.
  • 2,032 funds tracked by Wall St. Rank held CVS Health as of Q1 2021.

Based on Blue Chip Partners's 13F filing for Q1 2021, filed 4 May 2021.